Analyst Profile

Followed by 228 followers
.
Leah R. Cann

Leah R. Cann

Brookline Capital Markets
Wall Street Analyst
#7,716 out of 8,164 Wall Street Analysts
#23,199 out of 24,495 experts

Success Rate

38%
112 out of 296 transactions made a profit

Average Return

-6.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Leah R. Cann's trades since 2018 and holding each position for 1 Year would result in 37.84% of your transactions generating a profit, with an average return of -6.5% per rating.

Stock Rating Distribution

911Ratings
75.19% Buy
24.81% Hold
0.00% Sell
Distribution of Leah R. Cann's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Constellation Pharma
(CNST)
Rating:Buy
Date:Dec 11, 2018 - Dec 11, 2019
Return:+529.80%
The most profitable rating made by Leah R. Cann

Leah R. Cann's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
XLRN
Acceleron Pharma
Dec 02, 2018
Hold
Assigned
37Ratings
0.00%
Agios Pharma
Dec 03, 2018
Hold
Assigned
38Ratings
100%
+28.90%
Seagen
Dec 03, 2018
Hold
Assigned
47Ratings
0.00%
EPZM
Epizyme
Dec 04, 2018
Buy
Assigned
$27.00
(1736.73% Upside)
30Ratings
55%
+10.34%
Editas Medicine
Dec 04, 2018
Hold
Reiterated
17Ratings
0.00%
Amgen
Dec 04, 2018
Buy
Assigned
$224.00
(-21.61% Downside)
84Ratings
69%
+7.12%
Exelixis
Dec 05, 2018
Buy
Reiterated
$40.00
(144.65% Upside)
46Ratings
22%
-2.62%
NTGN
Neon Therapeutics
Dec 06, 2018
Buy
Assigned
6Ratings
0%
-75.42%
TSRO
Tesaro
Dec 07, 2018
Hold
Assigned
24Ratings
90%
+59.36%
Verastem
Dec 31, 2018
Hold
Assigned
33Ratings
18%
-23.02%
List of latest recommendations made by Leah R. Cann. Click to expand and see Leah R. Cann's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >